Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (the PROMISE Pediatric 6 to 11 Years Old Study)

NCT04613128 is registered in ClinicalTrials.gov with Nicole Hamblett as lead sponsor.

NCT NCT04613128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04613128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (the PROMISE Pediatric 6 to 11 Years Old Study)
Lead sponsor
Nicole Hamblett
Phase
Observational
Overall status
Completed
Start date
June 11, 2021
Completion date
December 8, 2025
Enrollment
125 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, cystic fibrosis in children